Rethinking Congenital Heart Disease in Preterm Neonates

Philip T Levy1, Alyssa R Thomas1, Ashley Wethall2

  • 1Division of Newborn Medicine, Department of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, MA.

Neoreviews
|May 31, 2022
PubMed

Insights

Prematurity and congenital heart disease (CHD) significantly increase infant mortality. Understanding factors influencing outcomes in preterm infants with CHD is crucial for improving care and survival rates.

Area of Science:

  • Neonatology
  • Pediatric Cardiology
  • Perinatal Medicine

Background:

  • Congenital heart disease (CHD) and prematurity are leading causes of infant mortality.
  • The combination of prematurity and CHD exacerbates mortality and morbidity risks.
  • Factors contributing to adverse outcomes in these infants are not fully understood.

Purpose of the Study:

  • To review current evidence on neonatal and cardiac outcomes in preterm infants with CHD.
  • To examine prenatal, perinatal, and postnatal factors influencing these outcomes.
  • To identify knowledge gaps and opportunities for research and clinical practice improvement.

Main Methods:

  • Literature review of current evidence.
  • Analysis of factors affecting outcomes.
  • Discussion of the evolving role of neonatologists in managing preterm infants with CHD.

Main Results:

  • Preterm infants with CHD face "double jeopardy" due to organ immaturity and cardiac disease.
  • Neonatologists play an increasingly integral role from fetal consultation to postoperative care.
  • Comprehensive understanding of prematurity and CHD is needed to inform clinical practice.

Conclusions:

  • Improved understanding of prematurity and CHD can enhance clinical practice.
  • Enhanced neonatologist involvement across the care continuum is vital.
  • Further research is needed to address knowledge gaps and improve outcomes for this vulnerable population.